Trametinib and M17, a novel small molecule inhibitor of AKT, display a synergistic antitumor effect in triple negative breast cancer cells through the AKT/mTOR and MEK/ERK pathways
Autor: | Han, Hongwei, Yang, Minkai, Wen, Zhongling, Mei, Feng, Chen, Qingqing, Ma, Yudi, Lai, Xiaohui, Zhang, Yahan, Fang, Rongjun, Yin, Tongming, Sun, Shucun, Wang, Xiaoming, Qi, Jinliang, Lin, Hongyan, Yang, Yonghua |
---|---|
Zdroj: | In Bioorganic Chemistry January 2025 154 |
Databáze: | ScienceDirect |
Externí odkaz: |